老年人糖尿病合并细菌性肝脓肿的超声介入治疗

目的 评价超声引导下穿刺抽脓及置管引流治疗老年人糖尿病合并细菌性肝脓肿的临床应用价值。方法 对46例老年糖尿病合并细菌性肝脓肿的患者进行经超声引导下脓汁抽吸、置管引流治疗。结果 46例患者穿刺抽脓及置管引流全部成功，治愈率93．5％（43／46），所有患者均未出现穿刺并发症。随后30、60、180d经门诊随访未见复发。结论 超声引导下介入治疗老年人糖尿病合并细菌性肝脓肿安全、有效，可以明显缩短疗程，可作为首选的治疗方法。     

超声引导介入治疗细菌性肝脓肿疗效观察

目的观察超声引导介入治疗细菌性肝脓肿的效果。方法 22例细菌性肝脓肿患者,其中10例脓腔直径<5 cm者,采用超声引导经皮穿刺抽吸药物冲洗术;12例脓腔直径≥5 cm者,采用超声引导经皮穿刺置管引流术。结果本组均完全治愈,术后均无严重并发症。其中4周治愈16例,8周治愈18例,6个月治愈22例。10例脓腔直径<5cm者,一次性抽吸治愈6例,二次3例,三次1例。12例脓腔直径≥5 cm者,4周治愈10例,8周13例,6个月12例。结论超声引导介入治疗细菌性肝脓肿疗效较好,可根据脓肿大小选择介入治疗方法。     

肝穿刺治疗糖尿病合并细菌性肝脓肿的护理

目的探析超声引导下经皮穿刺置管引流术治疗糖尿病合并细菌性肝脓肿的护理方法和护理效果。方法选取2012年2月—2013年8月该院50例患者均行超声引导下经皮穿刺置管引流术,术前术后实行心理护理、病情护理、用药护理、饮食护理、术后护理等全方位护理。结果无1例患者出现新发感染或并发症,均在痊愈后出院。结论全方位护理能减少行经皮穿刺置管引流术的糖尿病合并细菌性肝脓肿的治疗风险及新发感染或并发症的几率,保障且提高了治疗效果。     

B超引导下经皮肝穿刺置管引流术治疗细菌性肝脓肿42例

[目的]探讨B超引导下经皮肝穿刺置管引流术治疗细菌性肝脓肿的临床意义。[方法]回顾性分析采用B超介导下经皮肝穿刺置管引流治疗肝脓肿42例患者的临床资料,其中单发脓肿38例,2个以上多发脓肿4例。脓肿部位:肝右叶32例,左叶7例,左右肝叶3例。[结果]患者在置管后平均5 d体温恢复正常,引流量逐渐减少和消失,B超检查证实脓腔萎陷及无脓液。从置管到拔管时间为5～16 d,平均(9.6±2.3)d。42例患者经皮肝穿刺置管引流术治疗后痊愈41例,治愈率97.6%。[结论]B超引导下经皮肝穿刺置管引流在细菌性肝脓肿治疗中具有疗效确切,创伤小,恢复快的忧点,是肝脓肿的首选治疗方法。     

32例穿刺引流术治疗肝脓肿合并糖尿病实施优质护理的效果

目的分析对行穿刺引流术治疗的肝脓肿合并糖尿病患者采取优质护理的方案与效果。方法研究对象选择2018年12月—2019年12月期间该院收治的32例肝脓肿合并糖尿病患者。所有患者均行穿刺引流术治疗肝脓肿。在手术结束后对患者实施相应的优质护理方案,围绕血糖控制、置管后护理、引流护理所展开。之后比较患者在护理前后的血糖情况和发生的不良反应、感染现象,判定优质护理的作用。结果患者在优质护理后的空腹血糖值和餐后2 h血糖值均要显著优于护理前,且都在标准范围之内,差异有统计学意义(P0.05);32例患者中只有1例患者出现伤口渗血,1例患者出现置管脱落感染现象,其余患者均未产生严重并发症,证实了优质护理对患者恢复期间的实际作用。结论优质护理可以有效地改善患者的临床症状,且置管护理期间无明显的并发症出现,为护理工作提供了优化配置方案。     

超声引导下介入治疗艾滋病合并肝脓肿的临床价值

目的探讨超声引导下介入治疗艾滋病合并肝脓肿的临床价值。方法回顾性分析2009年10月至2014年1月在本科室行超声引导下介入治疗的艾滋病合并肝脓肿患者17例(31个肝脓肿)的治疗情况。结果全部17例患者中,单发脓肿9例,多发脓肿8例,脓肿总数31个。穿刺抽吸16个脓肿,置管引流15个脓肿,成功率100%,引流时间6~30天。手术未出现医护人员职业暴露,患者未出现不良反应,全部患者均治愈。1例患者肝脓肿治愈3个月后出现肝内新发脓肿,再次经皮穿刺抽吸后治愈。结论超声引导下介入治疗AIDS合并肝脓肿是一种安全、有效的治疗方式,亦是首选治疗方式。     

探析糖尿病合并肝脓肿置管引流的护理效果观察

目的探究置管引流的糖尿病合并肝脓肿患者实施围手术期护理的效果。方法选取2009年1月—2013年1月期间在该院接受治疗的30例实施经皮肝穿刺浓重引流术的糖尿病合并肝脓肿患者作为研究对象,给予其围手术期护理,对其临床资料进行回顾性的分析。结果通过B超引导下经皮肝穿刺脓肿置管引流冲洗治疗后。有24例在第2~3天体温恢复正常,21例患者在2~3周后临床症状和局部体征已经完全消失。结论给予进行置管引流的糖尿病合并肝脓肿患者实施围手术期护理可以取得良好的效果,值得临床推广。     

老年糖尿病合并细菌性肝脓肿患者的护理探讨

目的探讨老年糖尿病合并细菌性肝脓肿患者的护理探讨。方法选取该院在2014年1—10月期间共收治的糖尿病合并细菌性肝脓肿患者12例,对其在B超引导下穿刺置管引流,同时进行精心护理。结果所有患者在治疗(控制血糖以及控制感染)当天体温均有所下降,同时病情较治疗有明显改善,患者体征均恢复正常,无不良反应症状。结论在临床治疗糖尿病合并细菌性肝脓肿中,要严格控制患者的血糖含量,而且要合理使用抗生素来控制感染,要适当穿刺抽脓且护理及时,以此提高糖尿病合并细菌性肝脓肿患者的治愈率。     

糖尿病合并肝脓肿患者HbA1C水平与超声引导穿刺干预效果的关系

目的 研究糖尿病合并肝脓肿患者糖化血红蛋白(HbA1c)水平和超声引导穿刺干预效果的关系.方法 2018年1月至2019年12月蚌埠市第三人民医院收治的56例糖尿病合并肝脓肿患者,所有患者均在超声引导下行经皮穿刺置管引流术(PCD).根据HbA1c控制效果将56例患者分为控制良好组(HbA1c<7％)、控制一般组(7％...     

超声引导下穿刺置管治疗肝脓肿的临床效果回顾分析

目的 回顾分析介入置管引流治疗肝脓肿的效果及注意事项。 方法 以我院超声科自 2015 年 9 月至2019 年 9 月采用经皮穿刺置管治疗肝脓肿 49 例为研究对象,脓腔均经穿刺置管引流、并行脓腔冲洗、注药治疗、并根据药敏试验进行抗感染治疗。 结果 本研究 49 例患者均穿刺成功。 术后白细胞和中性粒细胞百分比均较术前明显减低(P 均<0. 05)。 术后及出院时 49 例患者脓肿直径明显小于术前,差异均有统计学意义( P均<0. 05);术后 25例患者体温 3 d 内恢复正常,16 例患者体温 3~ 7 d 内恢复正常,8 例患者体温超过 7 d 恢复正常。 患者均能较好耐受穿刺置管治疗,置管引流时间为 3~ 28 d,平均 13. 5 d,术中及术后未出现胆漏、感染及气胸等并发症,且均无复发迹象。 结论 超声引导下经皮穿刺置管引流治疗肝脓肿已逐渐取代大剂量药物治疗或手术治疗,且临床疗效可靠、并发症少,在临床治疗肝脓肿方法中优势明显。     

脓肿穿刺联合切开引流术治疗糖尿病合并深部脓肿的临床效果

目的分析脓肿穿刺联合切开引流术治疗糖尿病合并深部脓肿的临床效果。方法2015年12月—2019年12月抽取该院糖尿病合并深部脓肿患者140例。依手术方法分组,单一组(n=70)行CT超声引导下脓肿穿刺术治疗;联合组(n=70)在单一组基础上联合切开引流术治疗。比对两组术后血糖控制情况、疗效评价指标情况及并发症发生情况。结果术后与单一组比对,空腹血糖及餐后2 h血糖、并发症发生率、脓腔愈合时间、RBC计数正常时间、拔管标准时间、出院标准时间更低,差异有统计学意义(P<0.05)。结论针对糖尿病合并深部脓肿患者,应用脓肿穿刺联合切开引流术治疗效果优于单一应用CT超声引导下脓肿穿刺术,临床治疗效果更佳。     

The prognostic factors of severe amebic liver abscess: a retrospective study of 125 cases.

One hundred twenty-five cases of amebic liver abscess were diagnosed at Chang Gung Memorial Hospital in Taiwan from January 1981 to December 1989. An analysis of possible prognostic factors for severe amebic liver abscess was done retrospectively. The majority of the patients came from the southern part of Taiwan. Severe amebic liver abscess was defined as the rupture of an abscess that was resistant to 72 hr of medical treatment, or complicated by secondary bacterial infection. The results showed significant differences between patients with severe liver abscess and those with more moderate forms of amebic liver abscess in indices such as jaundice, hemoglobin and serum bilirubin levels, and dyspnea, as well as in pulmonary changes (right diaphragm elevation, right pleural effusion) seen on chest radiographs. Those patients with diabetes mellitus also had greater evidence of severe liver abscess. Moderate cases that were treated with amebicides showed excellent responses (no mortality). Severe cases required, in addition to amebicide therapy, either percutaneous or surgical drainage of pus, especially in those patients with ruptured abscesses. Those patients with abscesses that ruptured into the thoracic cavity were treated by either thoracostomy or needle aspiration, and all were cured. Three patients died of abscess rupture into the abdominal cavity, associated with secondary bacterial infection. The overall mortality rate was 2.4%. These symptoms and signs of severe liver abscess are indicators of the need for intensive treatment such as aspiration or surgical drainage.     

Percutaneous drainage of liver and splenic abscess

42 patients with solitary (n = 34) and multiple (n = 8) abscesses of the liver (n = 36) and the spleen (n = 6) were treated with ultrasound guided percutaneous interventions. 38 patients (90%) underwent a total of 97 closed abscess aspirations using needles of 0.9 and 1.3 mm in diameter. In 4 cases (10%) percutaneous catheter drainage was performed. Intravenous antibiotics were used in all cases. Those patients with closed abscess aspiration additionally received local injection of aminoglycosides into the cavity. 40 out of the 42 patients could be treated successfully by percutaneous methods for a cure rate of 95.2%. Percutaneous drainage failure occurred in 2.4%. One patient with multiple liver abscesses and catheter drainage died from myocardial infarction (hospital mortality 2.4%). Complications of ultrasound-guided interventions included two minor bleedings, requiring no therapy, and one pleural empyema (complication rate 7.1%). There were no treatment related lethal complications. These results indicate that abscesses of the liver and the spleen up to 10 cm in diameter can be effectively treated by closed (repetitive) needle aspiration and antibiotic therapy with a relatively low rate of complications. About half of our patients with abscesses of more than 10 cm received percutaneous catheter drainage. On the basis of our experience surgical drainage of liver abscesses and splenectomy in splenic abscesses should be restricted to those cases with percutaneous drainage failure.     

Endoscopic transpapillary abscess drainage for a patient with giant pyogenic liver abscess

The primary modalities for management of liver abscesses are usually antibiotics and percutaneous drainage. However, in patients with ascites or bleeding tendency, the percutaneous puncture of liver abscesses may be unsuitable. We applied a new approach, nasobiliary tube drainage, for a giant pyogenic liver abscess following diagnostic endoscopic retrograde cholangiopancreatography. Pyogenic liver abscess is often biliary in origin, and this new approach includes assessment of biliary abnormality for the management of the abscess, enabling treatment of parients in whom puncture of the abscess is considered dangerous because of massive ascites around the liver. We propose that this procedure is useful in the management of a subgroup of patients with pyogenic liver abscess. To our knowledge, no previous reports of endoscopic transpapillary abscess drainage in pyogenic liver abscess are available.     

Non-operative management of pyogenic liver abscess

BackgroundLiver abscess is a serious disease traditionally managed by open drainage. The advances in interventional radiology over the last two decades have allowed a change in approach to this condition. We have reviewed our experience in managing liver abscess over the last 7 years.MethodsDetails of all patients admitted with liver abscess between 1995 and 2002 were prospectively entered onto our database. A review was performed to document the use of imaging and drainage techniques. Aetiology, morbidity, mortality and duration of hospital stay were recorded.ResultsForty-two patients (median age 53 [22–85] years; M:F 18:24) were admitted with liver abscess (multiple abscess 20); 19 cases were of portal tract origin, 16 cases were of biliary tract origin and 7 cases were spontaneous. Forty-one patients were managed non-operatively, all received antibiotics (cephalo-sporins 76%, metronidazole 88%, quinolones 33%). Diagnosis was made on ultrasound scan (22) or CT (20). Five patients were managed with antibiotics alone. Fifteen patients were managed initially with percutaneous aspiration and five subsequently required percutaneous drainage. Twenty-one patients had primary percutaneous drainage, nine requiring a further procedure (aspiration 3, drainage 6). One patient underwent hepatic resection. Median hospital stay was 16 (6–35) days. There was one death, but no procedure-related morbidity.DiscussionNon-operative management of solitary and multiple liver abscesses is safe and effective.     

单腔中心静脉导管经皮穿刺留置冲洗治疗肺脓肿26例分析

目的探讨单腔中心静脉导管经皮穿刺留置冲洗治疗肺脓肿的效果。方法对26例肺脓肿患者采用单腔中心静脉导管经皮穿刺置人肺脓腔,脓液行细菌培养,根据药敏选择抗生素,同时应用0．5％甲硝唑溶液或敏感抗生素稀释液反复冲洗脓腔,直到脓液极少且清亮,脓腔闭合,可拔出引流管。结果26例患者经15—46d治愈出院,无并发症发生。结论单腔中心静脉导管经皮穿刺留置冲洗治疗肺脓肿安全可靠,值得在临床上推广应用。     

Isolated tubercular liver abscess in children treated with percutaneous isoniazid infusion

Isolated Tubercular liver abscess is mainly reported in adult patients. We report two cases of isolated tubercular liver abscess in paediatric patients. Diagnosis was made by clinical and ultrasound guided aspiration of pus showing acid fast bacilli in one case. In second case, biopsy of the abscess wall was confirmatory. In both cases percutaneous drainage of pus and transcatheter infusion of Isoniazid was given. After two weeks of infusion no acid fast bacilli was detected and cavity size decreased. Direct infusion of anti-tubercular drugs is more efficient than systemic therapy alone. This is first of its kind in treating isolated tubercular abscess in paediatric patients. So, percutaneous infusion of anti-tubercular agents can be considered in the treatment of tubercular liver abscess.     

Intracavitary contrast-enhanced ultrasound in abscess drainage – feasibility and clinical value

Objective. To evaluate the usefulness of intracavitary-applied contrast-enhanced ultrasound (ICCEUS) with BR1 in ultrasound-guided puncture and drainage of abdominal and pelvic abscesses. Material and methods. A total of 71 consecutive patients received ICCEUS after placement of a drainage catheter or a needle in abdominal or pelvic abscesses. Portions of 0.1 ml of BR1 and 20 ml of saline were injected through the drainage catheter or needle. Ultrasound recordings were evaluated to answer the following questions: correct placement of the catheter by showing enhancement in the cavity and the drain – ICCEUS findings suggesting incomplete enhancement in all abscess cavities – enhancement in non-abscess structures. Results. About 52% of patients had liver, 14% of patients had intraperitoneal, 11% had subphrenic, 14% had retroperitoneal, 6% had splenic, and 4% had pelvic abscesses. The majority of the patients received drain placement with 10-F using trocar technique. Enhancement in the drain or needle was seen in all patients. In 2% of patients, during the initial approach, a dislodgment of the catheter from the abscess cavity was diagnosed. Due to non-enhancing abscess compartments, in 36% of the patients more than one drainage treatment was necessary at the time of the first approach. In 14% of the patients communication with surrounding structures was diagnosed. Additional treatment resulted in 4% of cases. Conclusion. ICCEUS was helpful in all patients to confirm correct placement of drain or puncture needle. In 40% of patients, as a consequence of ICCEUS, additional therapy was scheduled, either additional drainage or abscess puncture, endoscopic retrograde drainage of the biliary or pancreatic duct or thoracic intervention.